APOA1 and Cirrhosis: This highlights the importance of investigating interventions aimed at preserving or restoring small HDL particles, including ApoA-I mimetic peptides, lifestyle modifications, and novel pharmacological agents, for their potential to ameliorate cirrhosis-related complications.